CAS-ViewAlert

View Alert




Originator:		DHSC & NHS England and Improvement: Supply disruption alert
Issue date:		29-Nov-2019 15:43:10
This alert has been issued to:
		Care Trusts Mental Health Trusts Specialists Trusts NHS Regional Offices Learning Disabilities Trusts Mental Health & Social Care Trusts Ambulance Trusts Mental Health & Learning Disabilities Trusts Acute Trusts Community Trusts
		MHRA (Medicines) Drug Alerts (Various Recipients) Other contacts Independent Healthcare Providers (registered with CAS) Clinical Commissioning Groups Ofsted recipients Social Care Providers (registered with CAS) MHRA (Medicines) Drug Alerts - Non-NHS Recipients Director of Public Health GP - Locum NHS 111 and Out of hours providers GP Practices DHSC Supply Disruption - Medicines
Action category:		Action
Title:		Emerade 150 microgram, 300 microgram and 500 microgram adrenaline auto-injector devices
Broadcast content:		All Emerade devices will be unavailable for the foreseeable future. A class 2 recall of this product was issued via this drug alert on 28 November. This alert contains a management plan which has been developed in collaboration with NHS England and NHS Improvement, the British Society for Allergy & Clinical Immunology (BSACI), the MHRA and National patient groups.
Additional information:		NHS England Regional Offices: please cascade this alert to all primary care contractors.
Alert reference:		SDA/2019/010
Action underway deadline:		03-Dec-2019
Action complete deadline:		31-Jan-2020
Attachments:		SDA-2019-010.pdf